Heart disease affects approximately 10 percent of dogs in their lifetime1 VETMEDIN® (pimobendan) from Boehringer Ingelheim is the only medication approved to treat preclinical mitral valve disease in ...

Dilated cardiomyopathy is the most common cause of congestive heart failure in some large dog breeds, including doberman pinschers, Saint Bernards and Great Danes, and is often inherited. DCM causes ...

The FDA approved the first drug designed to delay congestive heart failure in dogs The medication targets dogs with early heart disease before symptoms develop Early treatment may improve lifespan and ...

Proactive client education and regular physical examinations give veterinarians the opportunity to extend symptom-free time in cases of mitral valve disease, one of the most common cardiac diseases ...

Heart disease is a relatively common condition in dogs, especially in older dogs. In fact, it is estimated that approximately 10 percent of dogs seen by primary care veterinarians have some form of ...

Boehringer Ingelheim, a global leader in animal health, announced that the US Food and Drug Administration (FDA) has approved Vetmedin (pimobendan) chewable tablets and Vetmedin solution (pimobendan ...

DULUTH, Ga., Jan. 19, 2026 /PRNewswire/ -- Boehringer Ingelheim, a global leader in animal health, today announced that the U.S. Food and Drug Administration (FDA) has approved VETMEDIN (pimobendan) ...